Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Forsythoside A Alleviates Hypertensive Nephropathy by Promoting Mitophagy and Inhibiting Ferroptosis via ASCL1-CCNB1/mTOR Pathway.

Cui X, Yang D, Zhang Z, Wang C, Li H, Sun J, Zhang T, Wang M · 2026 · Journal of Ethnopharmacology · Atlas ID CUI2026

What this study shows

Forsythoside A binds ASCL1 and blocks the downstream CCNB1/mTOR axis, promoting mitophagy and suppressing ferroptosis to protect against Ang II-induced hypertensive nephropathy in mice — without lowering blood pressure.

Abstract

ShowHide

Forsythoside A (FTA), the primary bioactive component of Forsythiae Fructus, exhibits anti-inflammatory and antioxidant activity. Hypertensive nephropathy (HN) models were established in C57BL/6 mice and NRK-52E cells using Ang II. FTA mitigated Ang II-induced renal injury by reducing renal dysfunction markers (Cr, BUN, Alb/Cr), restoring renal tissue architecture and decreasing inflammatory markers, without exerting antihypertensive effects. RNA sequencing revealed associations with mTOR and ASCL1.

Read the full abstract on PubMed →

At a glance

Evidence type A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: C57BL/6 mouse; NRK-52E rat kidney cells); the code names the system studied -- animal work can be rigorous and still not be human data.
Study type4 - Animal Study
Model systemC57BL/6 mouse; NRK-52E rat kidney cells
JournalJournal of Ethnopharmacology
Year2026
Peer reviewedYes
Record last updated2026-10-01
SourceDOI 10.1016/j.jep.2026.122346 · PMID 42665168

Extracted findings

These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.

InterventionForsythoside A
TargetASCL1-CCNB1/mTOR; mitophagy; ferroptosis
ModelMouse; rat kidney epithelial cells
EffectReduced renal dysfunction markers and inflammation; increased mitophagy, decreased ferroptosis

In the Atlas

Related topics

MitophagyForsythoside AFerroptosismTORASCL1

More studies on this topic

Cite this paper

ShowHide
Cui, X., Yang, D., Zhang, Z., Wang, C., Li, H., Sun, J., Zhang, T., & Wang, M. (2026). Forsythoside A Alleviates Hypertensive Nephropathy by Promoting Mitophagy and Inhibiting Ferroptosis via ASCL1-CCNB1/mTOR Pathway. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2026.122346

@article{CUI2026,
  author       = {Cui, X. and Yang, D. and Zhang, Z. and Wang, C. and Li, H. and Sun, J. and Zhang, T. and Wang, M.},
  title        = {{Forsythoside A Alleviates Hypertensive Nephropathy by Promoting Mitophagy and Inhibiting Ferroptosis via ASCL1-CCNB1/mTOR Pathway}},
  journal      = {Journal of Ethnopharmacology},
  year         = {2026},
  doi          = {10.1016/j.jep.2026.122346},
  note         = {PMID: 42665168},
}

Cite this Atlas record

The record is the Atlas's own work — the evidence label, the extracted findings and the links. It is cited as part of the dataset, not as the paper.

Barton, O. (2026). Oliver's mTOR Atlas (record CUI2026) [Data set]. https://mtor-atlas.org/study/CUI2026/ · Dataset DOI 10.5281/zenodo.22059963

@misc{atlas_CUI2026,
  author       = {Barton, Oliver},
  title        = {{Oliver's mTOR Atlas}, record CUI2026},
  howpublished = {Data set},
  year         = {2026},
  url          = {https://mtor-atlas.org/study/CUI2026/},
  doi          = {10.5281/zenodo.22059963}
}
Was this page useful?